SEC Form 4 · accession 0001127602-15-020529
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
Jun 11, 2015
Accepted (ET)
Jun 11, 2015 · 9:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 11, 2015 | M | 4,115 | $34.56 | A | 4,355 | D | |
| Common StockF3 | Jun 11, 2015 | S | 4,115 | $182.7961 | D | 240 | D | |
| Common StockF2 | Jun 11, 2015 | M | 5,547 | $30.75 | A | 5,787 | D | |
| Common StockF4 | Jun 11, 2015 | S | 500 | $182.096 | D | 5,287 | D | |
| Common StockF5 | Jun 11, 2015 | S | 1,101 | $182.9426 | D | 4,186 | D | |
| Common StockF6 | Jun 11, 2015 | S | 1,603 | $184.2945 | D | 2,583 | D | |
| Common StockF7 | Jun 11, 2015 | S | 1,023 | $185.2194 | D | 1,560 | D | |
| Common StockF8 | Jun 11, 2015 | S | 1,320 | $186.2996 | D | 240 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 625,031 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $34.56 | Jun 11, 2015 | M | 4,115 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 4,115 | 94,660 | D |
| Stock OptionsF2 | $34.56 | Jun 11, 2015 | M | 5,547 | D | Dec 30, 2005 | Dec 30, 2015 | Common Stock | 5,547 | 89,113 | D |
Explanation of responses
- F1This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F2Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- F3This transaction was executed in multiple trades at prices ranging from $182.60 to $182.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $181.56 to $182.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $182.60 to $183.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $183.73 to $184.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $184.79 to $185.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $185.86 to $186.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.